Related references
Note: Only part of the references are listed.Precision Oncology in Surgery Patient Selection for Operable Pancreatic Cancer
Stephan B. Dreyer et al.
ANNALS OF SURGERY (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
Eva Versteijne et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Gene Expression Signature in Surgical Tissues and Endoscopic Biopsies Identifies High-Risk T1 Colorectal Cancers
Raju Kandimalla et al.
GASTROENTEROLOGY (2019)
A genomewide transcriptomic approach identifies a novel gene expression signature for the detection of lymph node metastasis in patients with early stage gastric cancer
Daisuke Izumi et al.
EBIOMEDICINE (2019)
Clinical Impact of Neoadjuvant Chemotherapy and Chemoradiotherapy in Borderline Resectable Pancreatic Cancer: Analysis of 884 Patients at Facilities Specializing in Pancreatic Surgery
Yuichi Nagakawa et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
A Comprehensive Assessment of Accurate Lymph Node Staging and Preoperative Detection in Resected Pancreatic Cancer
Toshiro Masuda et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2018)
A MicroRNA Signature Associated With Metastasis of T1 Colorectal Cancers to Lymph Nodes
Tsuyoshi Ozawa et al.
GASTROENTEROLOGY (2018)
Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma A Phase 2 Clinical Trial
Janet E. Murphy et al.
JAMA ONCOLOGY (2018)
ASO Author Reflections:Do Distinct Patternsof Recurrence Impact thePrognosis of Patients With Resected Pancreatic Ductal Adenocarcinoma?
Vincent P. Groot et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Surgery for Pancreatic Cancer after neoadjuvant treatment
Thilo Hackert
ANNALS OF GASTROENTEROLOGICAL SURGERY (2018)
Endoscopic ultrasound-guided fine-needle aspirate-derived preclinical pancreatic cancer models reveal panitumumab sensitivity in KRAS wild-type tumors
William Berry et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Pancreatic Adenocarcinoma, Version 2.2017
Margaret A. Tempero et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2017)
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
John P. Neoptolemos et al.
LANCET (2017)
Preoperative Gemcitabine-based Chemoradiation Therapy for Borderline Resectable Pancreatic Cancer Impact of Venous and Arterial Involvement Status on Surgical Outcome and Pattern of Recurrence
Hidenori Takahashi et al.
ANNALS OF SURGERY (2016)
Current standards and new innovative approaches for treatment of pancreatic cancer
Thierry Conroy et al.
EUROPEAN JOURNAL OF CANCER (2016)
Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline
Alok A. Khorana et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)
Katsuhiko Uesaka et al.
LANCET (2016)
Adjuvant and Neoadjuvant Therapy for Pancreatic Cancer
Daneng Li et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2016)
Prospective validation of microRNA signatures for detecting pancreatic malignant transformation in endoscopic-ultrasound guided fine-needle aspiration biopsies
Adam E. Frampton et al.
ONCOTARGET (2016)
Is Equipment Development Stifling Innovation in Radiation Oncology?
J. Martin Brown et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Differences Between Colon Cancer Primaries and Metastases Using a Molecular Assay for Tumor Radiation Sensitivity Suggest Implications for Potential Oligometastatic SBRT Patient Selection
Kamran A. Ahmed et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Integration of a Radiosensitivity Molecular Signature Into the Assessment of Local Recurrence Risk in Breast Cancer
Javier F. Torres-Roca et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Importance of resectability status in neoadjuvant treatment for pancreatic cancer
Masayuki Sho et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2015)
Optimal indication of neoadjuvant chemoradiotherapy for pancreatic cancer
Masayuki Sho et al.
LANGENBECKS ARCHIVES OF SURGERY (2015)
Radiosensitivity index predicts for survival with adjuvant radiation in resectable pancreatic cancer
Tobin Strom et al.
RADIOTHERAPY AND ONCOLOGY (2015)
Neoadjuvant Therapy is Associated with a Reduced Lymph Node Ratio in Patients with Potentially Resectable Pancreatic Cancer
Christina L. Roland et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Postoperative prognosis of pancreatic cancer with para-aortic lymph node metastasis: a multicenter study on 822 patients
Masayuki Sho et al.
JOURNAL OF GASTROENTEROLOGY (2015)
Reappraisal of Peritoneal Washing Cytology in 984 Patients with Pancreatic Ductal Adenocarcinoma Who Underwent Margin-Negative Resection
Sohei Satoi et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2015)
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Lola Rahib et al.
CANCER RESEARCH (2014)
Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer The CONKO-001 Randomized Trial
Helmut Oettle et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Pathological and clinical impact of neoadjuvant chemoradiotherapy using full-dose gemcitabine and concurrent radiation for resectable pancreatic cancer
Masayuki Sho et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2013)
Perineural Invasion and Lymph Node Involvement as Indicators of Surgical Outcome and Pattern of Recurrence in the Setting of Preoperative Gemcitabine-Based Chemoradiation Therapy for Resectable Pancreatic Cancer
Hidenori Takahashi et al.
ANNALS OF SURGERY (2012)
Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma
Deyali Chatterjee et al.
CANCER (2012)
Validation of a Radiosensitivity Molecular Signature in Breast Cancer
Steven A. Eschrich et al.
CLINICAL CANCER RESEARCH (2012)
A GENE EXPRESSION MODEL OF INTRINSIC TUMOR RADIOSENSITIVITY: PREDICTION OF RESPONSE AND PROGNOSIS AFTER CHEMORADIATION
Steven A. Eschrich et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
SYSTEMS BIOLOGY MODELING OF THE RADIATION SENSITIVITY NETWORK: A BIOMARKER DISCOVERY PLATFORM
Steven Eschrich et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype
Gillian C. Barnett et al.
NATURE REVIEWS CANCER (2009)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Share Paper
